Apnimed Reports Inducement Grants
Apnimed, Inc. reported inducement grants under Nasdaq Listing Rule 5635(c)(4). The company is a late-stage clinical pharmaceutical company focused on sleep-related breathing disorders.
Apnimed, Inc. reported inducement grants under Nasdaq Listing Rule 5635(c)(4). The company is a late-stage clinical pharmaceutical company focused on sleep-related breathing disorders.